Scholarly Index
Jennifer R. Brown
Dana-Farber Cancer Institute; 43,151 total citations; 807 total publications; best world rank #7
Dana-Farber Cancer Institute
43,151Total citations
807Total publications
89H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Chronic Lymphocytic Leukemia Research | Lifetime | 75 | US 47 | 99.71 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 59 | US 29 | 99.60 |
| Lymphoma Diagnosis and Treatment | Lifetime | 94 | US 46 | 99.68 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 99 | US 60 | 99.43 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 110 | US 65 | 98.96 |
| Advanced Breast Cancer Therapies | Lifetime | 205 | US 100 | 98.28 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 554 | US 131 | 97.12 |
| Acute Lymphoblastic Leukemia research | Lifetime | 977 | US 466 | 96.79 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 330 | US 152 | 96.10 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 9 | US 6 | 99.79 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 10 | US 5 | 99.76 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 9 | US 3 | 99.60 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 7 | US 5 | 98.33 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 38 | US 26 | 99.21 |
| Gastrointestinal Tumor Research and Treatment | 2021-2025 | 233 | US 29 | 93.78 |
| Advanced Breast Cancer Therapies | 2021-2025 | 366 | US 134 | 93.39 |